Rituximab beats mycophenolate mofetil in pemphigus vulgaris Presented ByProf. Pascal Joly, Rouen University Hospital, France TrialPhase 3, PEMPHIX, Ritux 3 ConferenceEADV 2019 9 December, 2019 19:52